Skip to main content
. 2020 Mar 19;5(12):6588–6597. doi: 10.1021/acsomega.9b04316

Figure 3.

Figure 3

DCFDA assay results showing that MWCNTs and GONRs treatment decreased the ROS production in B16 F10 cells. All data points were done in triplicates (*P < 0.01; Student’s t-test).